683 related articles for article (PubMed ID: 12497749)
1. [Interaction between sildenafil and calcineurin inhibitors in renal transplant recipients with erectile dysfunction].
Cofán F; Gutiérrez R; Beardo P; Campistol JM; Oppenheimer F; Alcover J
Nefrologia; 2002; 22(5):470-6. PubMed ID: 12497749
[TBL] [Abstract][Full Text] [Related]
2. Investigation on interaction between tacrolimus and sildenafil in kidney-transplanted patients with erectile dysfunction.
Christ B; Brockmeier D; Hauck EW; Kamali-Ernst S
Int J Clin Pharmacol Ther; 2004 Mar; 42(3):149-56. PubMed ID: 15049434
[TBL] [Abstract][Full Text] [Related]
3. Sildenafil citrate treatment for erectile dysfunction after kidney transplantation.
Zhang Y; Guan DL; Ou TW; Wang Y; Chen X; Xing NZ; Zhang XD; Yang Y
Transplant Proc; 2005 Jun; 37(5):2100-3. PubMed ID: 15964350
[TBL] [Abstract][Full Text] [Related]
4. [Sildenafil citrate for erectile dysfunction in male kidney transplant recipients].
Liu F; Zhang G; Ji X; Huang C; Wang P; Fan M
Zhonghua Nan Ke Xue; 2004 Jun; 10(6):455-7. PubMed ID: 15267215
[TBL] [Abstract][Full Text] [Related]
5. Interactions of sildenafil and tacrolimus in men with erectile dysfunction after kidney transplantation.
Christ B; Brockmeier D; Hauck EW; Friemann S
Urology; 2001 Oct; 58(4):589-93. PubMed ID: 11597545
[TBL] [Abstract][Full Text] [Related]
6. Treatment of erectile dysfunction with sildenafil citrate in renal allograft recipients: a randomized, double-blind, placebo-controlled, crossover trial.
Sharma RK; Prasad N; Gupta A; Kapoor R
Am J Kidney Dis; 2006 Jul; 48(1):128-33. PubMed ID: 16797395
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus.
Hesselink DA; van Schaik RH; van der Heiden IP; van der Werf M; Gregoor PJ; Lindemans J; Weimar W; van Gelder T
Clin Pharmacol Ther; 2003 Sep; 74(3):245-54. PubMed ID: 12966368
[TBL] [Abstract][Full Text] [Related]
8. Erectile dysfunction in kidney transplanted patients: efficacy of sildenafil.
Russo D; Musone D; Alteri V; Cindolo L; Lanzillo B; Federico S; Andreucci VE
J Nephrol; 2004; 17(2):291-5. PubMed ID: 15293531
[TBL] [Abstract][Full Text] [Related]
9. A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year.
Ciancio G; Burke GW; Gaynor JJ; Mattiazzi A; Roth D; Kupin W; Nicolas M; Ruiz P; Rosen A; Miller J
Transplantation; 2004 Jan; 77(2):244-51. PubMed ID: 14742989
[TBL] [Abstract][Full Text] [Related]
10. Calcineurin inhibitors in pediatric renal transplant recipients.
Filler G
Paediatr Drugs; 2007; 9(3):165-74. PubMed ID: 17523697
[TBL] [Abstract][Full Text] [Related]
11. Progressive decline in tacrolimus clearance after renal transplantation is partially explained by decreasing CYP3A4 activity and increasing haematocrit.
de Jonge H; Vanhove T; de Loor H; Verbeke K; Kuypers DR
Br J Clin Pharmacol; 2015 Sep; 80(3):548-59. PubMed ID: 26114223
[TBL] [Abstract][Full Text] [Related]
12. A transient increase of calcineurin phosphatase activity in living-donor kidney transplant recipients with acute rejection.
Fukudo M; Yano I; Katsura T; Ito N; Yamamoto S; Kamoto T; Ogawa O; Inui K
Drug Metab Pharmacokinet; 2010; 25(5):411-7. PubMed ID: 20834189
[TBL] [Abstract][Full Text] [Related]
13. Increase in renal vascular resistance after intake of cyclosporin A and tacrolimus and reversal by nitroglycerin spray: a study in patients with stable renal allograft function.
Weingart C; Leingärtner T; Bergler T; Krüger B; Böger C; Mack M; Banas B; Krämer BK
Int J Clin Pharmacol Ther; 2006 Sep; 44(9):422-7. PubMed ID: 16995330
[TBL] [Abstract][Full Text] [Related]
14. Erectile dysfunction and the effects of sildenafil treatment in patients on haemodialysis and continuous ambulatory peritoneal dialysis.
Türk S; Karalezli G; Tonbul HZ; Yildiz M; Altintepe L; Yildiz A; Yeksan M
Nephrol Dial Transplant; 2001 Sep; 16(9):1818-22. PubMed ID: 11522864
[TBL] [Abstract][Full Text] [Related]
15. Sildenafil: a review of its use in erectile dysfunction.
Langtry HD; Markham A
Drugs; 1999 Jun; 57(6):967-89. PubMed ID: 10400408
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and factors associated with successful outcome of sildenafil citrate use for erectile dysfunction after radical prostatectomy.
Raina R; Lakin MM; Agarwal A; Mascha E; Montague DK; Klein E; Zippe CD
Urology; 2004 May; 63(5):960-6. PubMed ID: 15134989
[TBL] [Abstract][Full Text] [Related]
17. Early experience with sildenafil for the treatment of erectile dysfunction in renal transplant recipients.
Barrou B; Cuzin B; Malavaud B; Petit J; Pariente JL; Buchler M; Cormier L; Benoit G; Costa P
Nephrol Dial Transplant; 2003 Feb; 18(2):411-7. PubMed ID: 12543900
[TBL] [Abstract][Full Text] [Related]
18. CYP3A4/5 polymorphisms affect the blood level of cyclosporine and tacrolimus in Chinese renal transplant recipients.
Li DY; Teng RC; Zhu HJ; Fang Y
Int J Clin Pharmacol Ther; 2013 Jun; 51(6):466-74. PubMed ID: 23557867
[TBL] [Abstract][Full Text] [Related]
19. Evaluation and therapeutic regulation of erectile dysfunction with visual stimulation test. An objective approach by using sildenafil citrate test.
Erbağci A; Yagci F; Sarica K; Ozbek E; Topcu O
Urol Int; 2002; 69(1):21-6. PubMed ID: 12119434
[TBL] [Abstract][Full Text] [Related]
20. Sildenafil (Viagra) in kidney transplant recipients with erectile dysfunction.
Espinoza R; Melchor JL; Gracida C
Transplant Proc; 2002 Feb; 34(1):408-9. PubMed ID: 11959347
[No Abstract] [Full Text] [Related]
[Next] [New Search]
